In a time when misinformation and political theater often drown out facts, President Trump’s message matters more than ever.
Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move along the messenger molecule, reading the genetic code as they go. Using this ...
Why are vaccines so hard to make? The fda approved two mRNA vaccines for COVID-19, but it was a challenge to make this type of vaccine work. In fact, it took decades of research to get us to the point ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.
Out-of-whack thyroid hormones during pregnancy in mothers with pre-pregnancy thyroid dysfunction may increase the child's ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.
C&EN networking event in New York City. Please join us if you’re in town! Here’s a link to the invitation. Questions? Comments? Tips? Let us know. Email Michael McCoy, C&EN’s executive editor for ...
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John ...
Multi-omics analyses reveal redundant functions of yeast mRNA decapping activators Scd6 and Edc3 in facilitating recruitment of helicase Dhh1 and accelerating degradation of transcripts required for ...
This study presents a valuable tool named TSvelo, a computational framework for RNA velocity inference that models transcriptional regulation and gene-specific splicing. The evidence supporting the ...
IFLScience on MSN
Is mRNA The Future Of Flu Shots? New Vaccine 34.5 Percent More Effective Than Standard Shots In Trials
A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results